bioAffinity Technologies, Inc.: capital expenditure payments

What this measure means

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Exact concept: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2022-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• bioAffinity Technologies, Inc.: total assets
• bioAffinity Technologies, Inc.: total liabilities
• bioAffinity Technologies, Inc.: stockholders equity
• bioAffinity Technologies, Inc.: cash and cash equivalents
• bioAffinity Technologies, Inc.: net income or loss
• bioAffinity Technologies, Inc.: operating cash flow
• bioAffinity Technologies, Inc.: contract revenue excluding tax
• bioAffinity Technologies, Inc.: financing cash flow
• bioAffinity Technologies, Inc.: investing cash flow
• bioAffinity Technologies, Inc.: retained earnings or deficit
• bioAffinity Technologies, Inc.: basic weighted-average shares
• bioAffinity Technologies, Inc.: diluted weighted-average shares
• bioAffinity Technologies, Inc.: basic earnings per share
• bioAffinity Technologies, Inc.: diluted earnings per share
• bioAffinity Technologies, Inc.: income tax expense or benefit
• bioAffinity Technologies, Inc.: net property, plant and equipment
• bioAffinity Technologies, Inc.: share-based compensation expense
• bioAffinity Technologies, Inc.: operating income or loss
• bioAffinity Technologies, Inc.: current assets
• bioAffinity Technologies, Inc.: interest expense
• bioAffinity Technologies, Inc.: current liabilities
• bioAffinity Technologies, Inc.: current accounts payable
• bioAffinity Technologies, Inc.: operating expenses
• bioAffinity Technologies, Inc.: net inventory
• bioAffinity Technologies, Inc.: selling, general and administrative expense
• bioAffinity Technologies, Inc.: research and development expense

Inspect the source

Entity

bioAffinity Technologies, Inc. / CIK 0001712762

Captured

2026-09-21T17:26:51.140Z

SEC response SHA-256

fa5285c203869b9319360f2941167a3defa69f4ea9ca028f2147c358ba6a6129

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001712762.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))